How to Prepare Pharmacology for FMGE 2026: High-Yield Topics and Strategy

By Dr. Utsav Bhattacherjee, MBBS, MBA · 26 August 2026 · 9 min read

FMGE Pharmacology high yield topics

• Drug-of-choice scenarios — which drug is preferred in specific clinical situations, especially pregnancy, and why.
• Classic adverse drug reactions — the defined set of drug-ADR pairings that repeat across question formats.
• Antimicrobial classification and selection — mechanism-based classification and empirical choice logic.
• Pharmacokinetics fundamentals — first-order versus zero-order kinetics, and what determines dosing intervals.
• Drug interactions — the mechanism-based interactions that show up repeatedly.
• Antihypertensive and cardiovascular drug classification — mechanism, and the drug-of-choice logic across common clinical scenarios.

Drug-of-choice scenarios worth knowing cold

• Hypertension in pregnancy — methyldopa is the classic first choice, alongside labetalol and nifedipine; ACE inhibitors and ARBs are contraindicated due to fetotoxic effects.
• Status epilepticus — benzodiazepines (typically lorazepam or diazepam) for immediate seizure termination, followed by a longer-acting antiepileptic to prevent recurrence.
• Malaria (uncomplicated, chloroquine-sensitive) — chloroquine remains first-line where resistance is not established; artemisinin-based combination therapy is standard where chloroquine resistance is present.
• Opioid overdose — naloxone, a competitive opioid receptor antagonist, reverses respiratory depression rapidly.
• Anaphylaxis — intramuscular epinephrine is first-line and should not be delayed for antihistamines or corticosteroids, which are adjuncts, not substitutes.

Classic drug-ADR pairs

These pairings are tested constantly because they are unambiguous, single-answer facts — exactly the kind of content that rewards direct memorisation over conceptual reasoning.

Pharmacokinetics: first-order vs zero-order

Most drugs follow first-order kinetics, where a constant fraction (not a constant amount) of the drug is eliminated per unit time — this is why first-order drugs have a consistent half-life regardless of dose. A small number of clinically important drugs follow zero-order kinetics at therapeutic or toxic doses, where a constant amount is eliminated per unit time because the elimination pathway is saturated — phenytoin, ethanol and aspirin (at high or toxic doses) are the classic examples. The practical consequence worth knowing: zero-order drugs do not have a fixed half-life, and small dose increases near the saturation point can cause disproportionately large increases in drug concentration — which is exactly why phenytoin dosing requires closer monitoring than a typical first-order drug.

Antimicrobial selection logic

Rather than memorising every antibiotic’s spectrum in isolation, anchor your recall to the classification and its clinical logic:

• Beta-lactams (penicillins, cephalosporins) — inhibit cell wall synthesis; broadly useful but inactive against organisms lacking a cell wall.
• Aminoglycosides — inhibit protein synthesis (30S ribosomal subunit); require renal dose adjustment and monitoring due to nephrotoxicity and ototoxicity.
• Fluoroquinolones — inhibit DNA gyrase; broad-spectrum, but carry tendon rupture risk and are generally avoided in children and pregnancy due to effects on developing cartilage.
• Macrolides — inhibit protein synthesis (50S ribosomal subunit); useful alternative in penicillin-allergic patients for many indications.
• Metronidazole — active against anaerobes and certain protozoa; a classic drug interaction to remember is its disulfiram-like reaction with alcohol.

Drug interactions worth memorising

A small set of interaction mechanisms account for a disproportionate share of tested drug interactions. Warfarin’s narrow therapeutic index makes it a classic interaction partner — many drugs (including several antibiotics) potentiate its effect by inhibiting its metabolism, increasing bleeding risk, while enzyme inducers reduce its effect. The combination of ACE inhibitors or ARBs with potassium-sparing diuretics raises hyperkalemia risk, since both pathways reduce potassium excretion through different mechanisms. Combining serotonergic drugs (certain antidepressants, tramadol and others) raises the risk of serotonin syndrome. Recognising the shared underlying mechanism across a drug class, rather than memorising each interaction as an isolated fact, makes this category far more manageable.

Antihypertensive drug classification

Cardiovascular pharmacology is tested heavily enough to deserve its own organised pass. ACE inhibitors and ARBs both reduce angiotensin II activity, but only ACE inhibitors cause the characteristic dry cough, since that side effect comes from bradykinin accumulation — a pathway ARBs do not affect the same way. Calcium channel blockers split into dihydropyridines (primarily vasodilators, used for hypertension) and non-dihydropyridines like verapamil and diltiazem (which also slow AV conduction, making them useful for rate control but risky to combine with beta blockers due to additive bradycardia risk). Beta blockers reduce heart rate and myocardial oxygen demand, making them first-line after myocardial infarction, but require caution in reactive airway disease due to bronchospasm risk with non-selective agents. Thiazide diuretics are a common first-line choice for uncomplicated hypertension, with hypokalemia and hyperglycemia as their classic metabolic side effects.

CNS pharmacology: a few high-yield anchors

A handful of CNS drug concepts repeat often enough to prioritise specifically. Benzodiazepines act via GABA-A receptor potentiation, making them effective for seizures and anxiety but carrying real dependence and withdrawal risk with prolonged use; flumazenil is their specific reversal agent, though it carries its own seizure risk in dependent patients. Opioids act via mu-receptor agonism, and naloxone’s rapid reversal of respiratory depression is one of the most clinically important antidote relationships in the whole subject. Selective serotonin reuptake inhibitors are generally better tolerated than older antidepressant classes, but combining them with other serotonergic agents (including tramadol and certain migraine medications) raises the risk of serotonin syndrome — a mechanism worth knowing since it explains a whole category of drug interaction questions at once, rather than needing each pairing memorised separately.

Antidiabetic and GI drug highlights

Metformin remains first-line for type 2 diabetes, working primarily by reducing hepatic glucose production, and carries a notable risk of lactic acidosis in renal impairment — which is why renal function is checked before starting it and monitored during use. Sulfonylureas stimulate insulin secretion and carry a real hypoglycemia risk, unlike metformin, which does not cause hypoglycemia on its own. Proton pump inhibitors, used broadly for peptic ulcer disease and GERD, work by irreversibly inhibiting the gastric parietal cell proton pump, and their long-term use is increasingly associated with risks including reduced calcium absorption and increased fracture risk — a detail worth knowing given how commonly they are prescribed.

A smart study plan for FMGE Pharmacology

• Build a personal drug-of-choice and drug-ADR reference table early, since these are the two highest-yield, most directly testable categories in the subject.
• Learn antimicrobials and CNS drugs by mechanism class, not as an unstructured list — the mechanism explains both the spectrum and the major side effects, which makes recall far more efficient than rote memorisation.
• Prioritise the interaction mechanisms that recur across many drug combinations (enzyme induction and inhibition, additive toxicity, receptor-level interactions) over trying to memorise an exhaustive interaction list.
• Revisit this subject close to your exam date — its high density of discrete, memorisable facts holds up well under a compressed final review, similar to Biochemistry.

For the complete high-yield picture across every FMGE subject, see our FMGE high yield topics guide, and for how Pharmacology fits into your overall timeline, our FMGE December 2026 preparation strategy covers the sequencing across subjects.